Compare First Citizens BancShares Inc (FCNCA) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Citizens BancShares Inc vs Moderna, Inc. — how do they compare? First Citizens BancShares Inc trades at $2,127.41 (market cap $23.76B), while Moderna, Inc. trades at $66.39 (market cap $27.09B). The key difference: First Citizens BancShares Inc and Moderna, Inc. are close in size by market cap, and First Citizens BancShares Inc pays a 0.41% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| FCNCA | MRNA | |
|---|---|---|
Market Cap | $23.76B | $27.09B |
Sector | Sector/Thematic | Health |
52-Week High | $2.20K | $81.80 |
52-Week Low | $1.64K | $22.36 |
Dividend Yield | 0.41% | — |
Enterprise Value | — | $23.19B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
